2022 was another year of facing and overcoming challenges for people around the world. As we move into a new year, it is a good time to reflect on achievements and accomplishments. Throughout the year, the APGI has continued to support Pancreatic Cancer research projects through access to the bioresource, a summary of a few of the projects can be found here.
The resources that we provided included:
- Tissue Micro Arrays
- Patient Derived Cell Lines
- Tissue samples, fresh frozen and paraffin embedded
- Pancreatic Cancer pathology slide images
- Comprehensive Clinical Data
The APGI would like to acknowledge and gratefully thank the patients who have consented to be involved. Their invaluable contribution has allowed continued research in order to further better diagnosis, treatment and care of Pancreatic Cancer. We would also like to acknowledge the Leadership Executive Team, collaborators and support staff involved with the daily operation of the APGI.
The APGI will be closed from December 21st and returning on January 9th. From all of us at the APGI, we wish you a happy and healthy 2023.